Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature.
about
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerImproving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling.Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians.Maximal testosterone suppression in prostate cancer--free vs total testosterone(18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy studyAR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.Androgen Signaling in Prostate Cancer.Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer.Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.Hormone levels following surgical and medical castration: defining optimal androgen suppression.Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist.
P2860
Q29994552-48CDEA94-9CF4-4066-B649-54EDB78AD75AQ33589156-0C22E040-E645-4DD2-9447-98DF1B7FD910Q33803812-D08ED507-AF40-4603-83E4-37218C85B4C0Q35096022-D71E1864-CCAC-4825-89DF-975D0A2D8248Q35890956-B79BFDD1-3B1C-4CA8-BE35-36D0E683C23CQ37629545-4ECC9181-237C-4418-9370-7675589559C0Q38973231-6B2E83E2-BE97-4630-9B70-BD7933675D11Q39227656-F69A42A6-862B-4BAE-9E60-E3414DAB3882Q39756984-7A4307E8-147D-4DD9-BB59-FD9C1737284EQ47896453-F4D128EA-E39F-4C42-BF2D-20819147283EQ50125356-300ECD13-C1D5-4B91-AAFE-7740FF548863Q52572665-9865868A-D799-4140-A26C-E9D69A77CEF3Q53762958-6F85E88F-9507-4B00-AAE5-1F1C7FDE9C88Q55015269-2474CADA-A9D4-4640-A950-D273BB2753CF
P2860
Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Serum testosterone levels afte ...... sive review of the literature.
@en
type
label
Serum testosterone levels afte ...... sive review of the literature.
@en
prefLabel
Serum testosterone levels afte ...... sive review of the literature.
@en
P1433
P1476
Serum testosterone levels afte ...... sive review of the literature.
@en
P2093
Tsutomu Nishiyama
P304
P356
10.1016/J.UROLONC.2013.03.007
P577
2013-06-13T00:00:00Z